IL6 and prostate carcinoma: Also, Sutcliffe et al reported a positive association between T. vaginalis serostatus and overall prostate cancer risk, and suggested the possibility of prostate carcinogenesis due to activation of oncogenes by IL-6-STAT3 signaling [5, 51].